BRAF and metastatic malignant neoplasm in the lymph nodes: A number of studies have reported that BRAF mutation was associated with aggressive PTC characteristics, such as extrathyroidal extension, lymph node metastasis, tumor recurrence, decreased survival, and need for cervical reoperation [14–16].